FDA Approves Vanflyta

FDA Approves Vanflyta

FDA Approves Vanflyta (quizartinib) for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia TOKYO & BASKING RIDGE, N.J. July 20, 2023 –(BUSINESS WIRE)–Daiichi Sankyo…

Read More
FDA Approves Abrysvo

FDA Approves Abrysvo

FDA Approves Abrysvo (respiratory syncytial virus vaccine) for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults NEW YORK–(BUSINESS WIRE) May 31, 2023 —…

Read More
FDA Approves Epkinly

FDA Approves Epkinly

FDA Approves Epkinly (epcoritamab-bysp) Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) NORTH CHICAGO, Ill., May 19, 2023…

Read More
FDA Approves Mydcombi

FDA Approves Mydcombi

FDA Approves Mydcombi (tropicamide and phenylephrine hydrochloride) Ophthalmic Spray for Inducing Mydriasis NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an…

Read More